Total Payments
$14,348
2024 Payments
$1,222
Companies
37
Transactions
194
Medicare Patients
2,372
Medicare Billing
$192,316
Payment Breakdown by Category
Food & Beverage$9,193 (64.1%)
Travel$2,642 (18.4%)
Other$2,500 (17.4%)
Education$12.63 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,193 | 188 | 64.1% |
| Travel and Lodging | $2,642 | 4 | 18.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,500 | 1 | 17.4% |
| Education | $12.63 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $3,752 | 14 | $0 (2024) |
| Philips North America LLC | $1,091 | 1 | $0 (2023) |
| Philips Electronics North America Corporation | $970.82 | 3 | $0 (2023) |
| ABIOMED | $909.66 | 8 | $0 (2024) |
| Boston Scientific Corporation | $892.76 | 16 | $0 (2024) |
| Cardiovascular Systems Inc. | $883.25 | 8 | $0 (2018) |
| Medtronic, Inc. | $876.03 | 14 | $0 (2024) |
| Medtronic Vascular, Inc. | $622.06 | 10 | $0 (2020) |
| BIOTRONIK INC. | $447.34 | 4 | $0 (2024) |
| Siemens Medical Solutions USA, Inc. | $438.75 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,222 | 28 | CVRx, Inc. ($244.99) |
| 2023 | $2,617 | 25 | Philips North America LLC ($1,091) |
| 2022 | $1,964 | 34 | Philips Electronics North America Corporation ($425.40) |
| 2021 | $1,949 | 27 | Siemens Medical Solutions USA, Inc. ($438.75) |
| 2020 | $437.03 | 14 | Medtronic Vascular, Inc. ($125.00) |
| 2019 | $1,193 | 22 | Abbott Laboratories ($487.12) |
| 2018 | $1,107 | 13 | Cardiovascular Systems Inc. ($845.62) |
| 2017 | $3,861 | 31 | Abbott Laboratories ($2,794) |
All Payment Transactions
194 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/25/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/16/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Renal Denervation System | ||||||
| 11/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $92.59 | General |
| Category: Diabetes Care | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.92 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/08/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $22.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | BIOTRONIK INC. | Orsiro Mission (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $184.42 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/09/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $45.81 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/09/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $14.76 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/14/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/21/2024 | AngioDynamics, Inc. | ALPHAVAC (Device) | Food and Beverage | In-kind items and services | $47.30 | General |
| Category: VIT | ||||||
| 06/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.86 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Cardiology | ||||||
| 05/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $98.22 | General |
| 05/07/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Cardiology | ||||||
| 04/08/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $108.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.80 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/08/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 802 | 1,060 | $279,783 | $64,130 |
| 2022 | 8 | 807 | 1,029 | $266,019 | $61,003 |
| 2021 | 11 | 541 | 684 | $182,632 | $46,661 |
| 2020 | 7 | 222 | 281 | $78,059 | $20,523 |
Total Patients
2,372
Total Services
3,054
Medicare Billing
$192,316
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 122 | $65,985 | $16,202 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 179 | $69,250 | $15,887 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 201 | 256 | $70,011 | $15,236 | 21.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 53 | 53 | $35,181 | $8,199 | 23.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 204 | 339 | $15,560 | $3,521 | 22.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 62 | 67 | $11,450 | $2,440 | 21.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $10,575 | $2,283 | 21.6% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 23 | 23 | $1,771 | $361.32 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 177 | 234 | $64,584 | $14,882 | 23.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 78 | 78 | $52,182 | $11,680 | 22.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 65 | 80 | $43,635 | $10,434 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 97 | $38,024 | $8,899 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $23,322 | $5,636 | 24.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 116 | 132 | $22,440 | $5,396 | 24.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 202 | 318 | $18,444 | $3,396 | 18.4% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2022 | 44 | 44 | $3,388 | $679.05 | 20.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 122 | 166 | $43,800 | $11,650 | 26.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 60 | 60 | $39,596 | $10,191 | 25.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 41 | 52 | $27,444 | $7,099 | 25.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 63 | $23,760 | $6,341 | 26.7% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 26 | 26 | $13,658 | $3,345 | 24.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 145 | 218 | $12,644 | $2,474 | 19.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $9,080 | $2,239 | 24.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 15 | $4,515 | $1,253 | 27.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 23 | 25 | $4,168 | $1,107 | 26.5% |
About Dr. John Marshall, MD
Dr. John Marshall, MD is a Interventional Cardiology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184676413.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Marshall, MD has received a total of $14,348 in payments from pharmaceutical and medical device companies, with $1,222 received in 2024. These payments were reported across 194 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($9,193).
As a Medicare-enrolled provider, Marshall has provided services to 2,372 Medicare beneficiaries, totaling 3,054 services with total Medicare billing of $192,316. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Atlanta, GA
- Active Since 05/16/2006
- Last Updated 02/26/2021
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1184676413
Products in Payments
- Xience V coronary stent system (Device) $2,500
- (9547) IGT Systems Undivided (Device) $1,555
- Impella (Device) $909.66
- Peripheral Orbital Atherectomy System (Device) $828.21
- (9547) IGT Systems Und (Device) $425.40
- CoreValve Evolut (Device) $402.55
- LifeVest (Device) $355.85
- Resolute (Device) $305.90
- CorPath Imaging System (Device) $293.74
- Mitra Clip system (Device) $273.16
- Repatha (Biological) $272.44
- Barostim Neo System (Device) $244.99
- WATCHMAN Access System (Device) $240.75
- ELIQUIS (Drug) $236.14
- Orsiro Mission (Device) $218.34
- COREVALVE EVOLUT R (Device) $210.32
- RESOLUTE ONYX (Device) $208.33
- KENGREAL (Drug) $206.06
- FLOWTRIEVER CATHETER, S (Device) $183.26
- Xience Sierra Coronary Stent System (Device) $182.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Atlanta
Pradeep Yadav, M.d, M.D
Interventional Cardiology — Payments: $658,637
Interventional Cardiology $658,637
Dr. Charles Brown, Md, MD
Interventional Cardiology — Payments: $394,383
Interventional Cardiology $394,383
Wissam Jaber, M.d, M.D
Interventional Cardiology — Payments: $233,497
Interventional Cardiology $233,497
Dr. Katherine Kunkel, M.d, M.D
Interventional Cardiology — Payments: $173,198
Interventional Cardiology $173,198
Dr. Chandanreddy Devireddy, M.d, M.D
Interventional Cardiology — Payments: $132,103
Interventional Cardiology $132,103
Dr. George Hanzel, Md, MD
Interventional Cardiology — Payments: $55,561
Interventional Cardiology $55,561